AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36206005 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 18621
Study 34024186 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37
Study 34024186 — intervention group
Group type: COMPARATOR
Intervention: Indirect laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37
Study 34024186 — intervention group
Group type: EXPERIMENTAL
Intervention: Both direct and indirect laryngoscopy using a McGrath videolaryngoscope
Number of subjects: 37
Study 32138631 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962 (600 mg intraventricular dose)
Number of subjects: 289
Study 32138631 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral nimodipine)
Number of subjects: 289
Study 32138631 — intervention group
Group type: EXPERIMENTAL
Intervention: EG-1962
Number of subjects: 289
Study 32138631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 34391812 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% spinosad topical suspension
Number of subjects: 206
Study 34391812 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 206
Study 33179988 — intervention group
Group type: EXPERIMENTAL
Intervention: QSPR modelling of aliphatic compounds
Number of subjects: 309
Study 33179988 — intervention group
Group type: EXPERIMENTAL
Intervention: QSPR modelling of phenyl‐based compounds
Number of subjects: 309
Study 35894997 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-second fast-speed eccentric resistance training
Number of subjects: 22
Study 35894997 — intervention group
Group type: COMPARATOR
Intervention: 4-second slow-speed eccentric resistance training
Number of subjects: 22
Study 35894997 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall increase in 1-repetition maximum
Number of subjects: 22
Study 33975533 — intervention group
Group type: EXPERIMENTAL
Intervention: Women seeking abortion care
Number of subjects: 20
Study 32755396 — intervention group
Group type: COMPARATOR
Intervention: Circumferential pulmonary vein isolation (CPVI) alone
Number of subjects: 114
Study 32755396 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional electrical posterior box isolation (POBI)
Number of subjects: 114
Study 32755396 — intervention group
Group type: COMPARATOR
Intervention: CPVI alone
Number of subjects: 114
Study 32755396 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional POBI
Number of subjects: 114
Study 32755396 — intervention group
Group type: EXPERIMENTAL
Intervention: POBI
Number of subjects: 114
Study 35422053 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-transmucosal haloperidol 2.5 mg
Number of subjects: 80
Study 35422053 — intervention group
Group type: COMPARATOR
Intervention: Oral-transmucosal olanzapine 5 mg
Number of subjects: 80
Study 33952548 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention involving an information pack for schools and access to a local paediatric ophthalmology clinic for up to 5% of participating children.
Number of subjects: 0
Study 33952548 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (Control group).
Number of subjects: 0
Study 32293657 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 507
Study 32293657 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound treatment (CWT)
Number of subjects: 507
Study 36056388 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised intervention programme including modules such as Brief messaging, Clinical medication review, Medication schedule, Reminding messaging, Medication dispensing systems, Smart messaging, Referral to general practitioner, Unguided web-based Self Help Application for low mood.
Number of subjects: 300
Study 36056388 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised intervention programme
Number of subjects: 300
Study 36056388 — intervention group
Group type: COMPARATOR
Intervention: Usual care including access to a publicly available informative diabetes website.
Number of subjects: 300
Study 33707410 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (weekly sessions from January 22 to March 11, 2020)
Number of subjects: 22
Study 33707410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study 35964417 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine (10 or 20 mg)
Number of subjects: 106
Study 35964417 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200 or 400 mg)
Number of subjects: 106
Study 35964417 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 106
Study 33047488 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 160
Study 33047488 — intervention group
Group type: COMPARATOR
Intervention: Non-closed suction drainage (non-CSD)
Number of subjects: 160
Study 35752926 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot complex care intervention
Number of subjects: 805
Study 616357846 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH plus vacuum plus modeling
Number of subjects: 30
Study 616357846 — intervention group
Group type: COMPARATOR
Intervention: CCH plus vacuum only
Number of subjects: 30
Study 35652531 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant-based anti-emetic regimen
Number of subjects: 0
Study 34041719 — intervention group
Group type: COMPARATOR
Intervention: Sham ACB
Number of subjects: 121
Study 34041719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine ACB
Number of subjects: 121
Study 34041719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine ACB with MgSO4
Number of subjects: 121
Study 34041719 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (sham, ropivacaine ACB, ropivacaine ACB with MgSO4)
Number of subjects: 121
Study 32068285 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based therapeutic education intervention
Number of subjects: 0
Study 32068285 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32496448 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (gDT)
Number of subjects: 40
Study 32496448 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 40
Study 34836275 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinegar group (1.5 g acetic acid/day as liquid vinegar)
Number of subjects: 25
Study 34836275 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.015 g acetic acid/day as a pill)
Number of subjects: 25
Study 34836275 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinegar ingestion
Number of subjects: 25
Study 32697555 — intervention group
Group type: EXPERIMENTAL
Intervention: Defocus + AA92593 group
Number of subjects: 20
Study 32697555 — intervention group
Group type: COMPARATOR
Intervention: Defocus group
Number of subjects: 20
Study 33562216 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian-directed groceries (DDG)
Number of subjects: 43
Study 33562216 — intervention group
Group type: COMPARATOR
Intervention: Self-directed grocery shopping (SDG)
Number of subjects: 43
Study 35385090 — intervention group
Group type: EXPERIMENTAL
Intervention: PARS intervention (1-session secondary prevention module administered by trained SUD counselors)
Number of subjects: 906
Study 35385090 — intervention group
Group type: EXPERIMENTAL
Intervention: PARS intervention
Number of subjects: 906
Study 35385090 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 906
Study 33564993 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine and morphine (ITBM) group, n = 45
Number of subjects: 100
Study 33564993 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal bupivacaine (ITB) group, n = 42
Number of subjects: 100
Study 32233962 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetrician-gynecologists retrieving medication safety information during clinical visits
Number of subjects: 506
Study 32233962 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of potentially problematic 'safe lists' to patients
Number of subjects: 506
Study 32233962 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited counseling for reproductive-aged patients not actively planning a pregnancy
Number of subjects: 506
Study 32843260 — intervention group
Group type: EXPERIMENTAL
Intervention: Music pedagogical program
Number of subjects: 116
Study 32843260 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 33975736 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted serum uric acid levels
Number of subjects: 15666
Study 32856734 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC units stored not more than 7 days
Number of subjects: 2510
Study 32856734 — intervention group
Group type: COMPARATOR
Intervention: Oldest compatible RBC units
Number of subjects: 2510
Study 33641634 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 39
Study 33641634 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose
Number of subjects: 39
Study 33641634 — intervention group
Group type: EXPERIMENTAL
Intervention: Steviol glycosides
Number of subjects: 39
Study 33323057 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-assisted maturation (BAM) technique
Number of subjects: 300
Study 33323057 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (NO BAM)
Number of subjects: 300
Study 33010968 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pelvic floor physical therapy (12 weekly 60‐min sessions)
Number of subjects: 31
Study 33010968 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal pelvic floor physical therapy
Number of subjects: 31
Study 35045852 — intervention group
Group type: EXPERIMENTAL
Intervention: Question-answer format
Number of subjects: 2215
Study 35045852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact-only format
Number of subjects: 2215
Study 35045852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fact-myth format
Number of subjects: 2215
Study 32987839 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based meals
Number of subjects: 60
Study 32987839 — intervention group
Group type: COMPARATOR
Intervention: Meals with other cereals
Number of subjects: 60
Study 35236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node mapping without systematic lymphadenectomy
Number of subjects: 178
Study 35236752 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node mapping with systematic pelvic and para-aortic lymphadenectomy
Number of subjects: 178
Study 35236752 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node mapping with systematic lymphadenectomy
Number of subjects: 178
Study 35236752 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node mapping ± systematic lymphadenectomy
Number of subjects: 178
Study 32867593 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app exposure (50-MF, 100-MF, 200-MF)
Number of subjects: 25
Study 32867593 — intervention group
Group type: COMPARATOR
Intervention: Control (without smartphone app exposure) (50-CON, 100-CON, 200-CON)
Number of subjects: 25
Study 34311999 — intervention group
Group type: EXPERIMENTAL
Intervention: Return to diet at 2 weeks
Number of subjects: 0
Study 34311999 — intervention group
Group type: EXPERIMENTAL
Intervention: Return to diet at 4 weeks
Number of subjects: 0
Study 34311999 — intervention group
Group type: COMPARATOR
Intervention: Return to diet at 6 weeks (control group)
Number of subjects: 0
Study 35312632 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 14
Study 35312632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33117131 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS treatment
Number of subjects: 34
Study 33117131 — intervention group
Group type: COMPARATOR
Intervention: No-stim control treatment
Number of subjects: 34
Study 33567218 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet light-emitting diodes (LEDs) device emitting violet light (405-410 nm) without peroxide-containing bleaching gel
Number of subjects: 60
Study 33567218 — intervention group
Group type: COMPARATOR
Intervention: 35% hydrogen peroxide gel
Number of subjects: 60
Study 33567218 — intervention group
Group type: EXPERIMENTAL
Intervention: Both whitening protocols (Violet LED and 35% hydrogen peroxide)
Number of subjects: 60
Study 33567218 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet light alone
Number of subjects: 60
Study 32950853 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic touch-display
Number of subjects: 22
Study 32950853 — intervention group
Group type: COMPARATOR
Intervention: Tambourines
Number of subjects: 22
Study 35346348 — intervention group
Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention delivered regularly for 12 months
Number of subjects: 376
Study 35346348 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual + DIALOG scale
Number of subjects: 376
Study 33450192 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGGs) from the palate
Number of subjects: 18
Study 33450192 — intervention group
Group type: COMPARATOR
Intervention: Porcine collagen matrix (mucoderm)
Number of subjects: 18
Study 32311204 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 813
Study 32311204 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 813
Study 32311204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 813
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars Plana Vitrectomy (PPV)
Number of subjects: 88
Study 34520841 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic Retinopexy (PnR)
Number of subjects: 88
Study 34520841 — intervention group
Group type: COMPARATOR
Intervention: PnR without ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall with ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall without ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal metamorphopsia
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical metamorphopsia
Number of subjects: 88
Study 32892272 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 1381
Study 32892272 — intervention group
Group type: COMPARATOR
Intervention: Other studies
Number of subjects: 1381
Study 36463165 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR using hamstring tendon autograft
Number of subjects: 40
Study 36463165 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR using artificial LARS
Number of subjects: 40
Study 36463165 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR performed within 1 year of injury
Number of subjects: 40
Study 36463165 — intervention group
Group type: EXPERIMENTAL
Intervention: ACLR performed more than 1 year after injury
Number of subjects: 40
Study 32478863 — intervention group
Group type: EXPERIMENTAL
Intervention: 98% cannabidiol in oil (Tilray, Canada)
Number of subjects: 8
Study 32478863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 35702866 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine body wash, chlorhexidine mouthwash, and nasal mupirocin
Number of subjects: 0
Study 35702866 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical therapy improvements in silico
Number of subjects: 0
Study 34269387 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health technologies for behavior change and self-care
Number of subjects: 0
Study 32119928 — intervention group
Group type: EXPERIMENTAL
Intervention: HUNT tool
Number of subjects: 1241
Study 32119928 — intervention group
Group type: EXPERIMENTAL
Intervention: M-BERET tool
Number of subjects: 1241
Study 32119928 — intervention group
Group type: EXPERIMENTAL
Intervention: Kunzmann tool
Number of subjects: 1241
Study 32119928 — intervention group
Group type: COMPARATOR
Intervention: Gastroesophageal reflux disease (GERD) symptoms alone
Number of subjects: 1241
Study 32119928 — intervention group
Group type: COMPARATOR
Intervention: Frequency and duration of GERD
Number of subjects: 1241
Study 32119928 — intervention group
Group type: COMPARATOR
Intervention: All tools compared to GERD
Number of subjects: 1241
Study 33037726 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifekalant 0.4 mg/kg
Number of subjects: 0
Study 33037726 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifekalant 0.5 mg/kg
Number of subjects: 0
Study 33037726 — intervention group
Group type: COMPARATOR
Intervention: Nifekalant 0.3 mg/kg
Number of subjects: 0
Study 37032583 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nVNS device
Number of subjects: 40
Study 37032583 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 40
Study 34886327 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 20
Study 34886327 — intervention group
Group type: EXPERIMENTAL
Intervention: Future Thinking Priming (FTP)
Number of subjects: 20
Study 34886327 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 20
Study 32594922 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quintile of gestational weight gain (GWG) rate
Number of subjects: 13765
Study 32594922 — intervention group
Group type: COMPARATOR
Intervention: Middle quintile of gestational weight gain (GWG) rate
Number of subjects: 13765
Study 35650639 — intervention group
Group type: EXPERIMENTAL
Intervention: Zibotentan
Number of subjects: 16
Study 35650639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34397821 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (25 IU)
Number of subjects: 90
Study 34397821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32038200 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive eye tracked virtual reality (VR)
Number of subjects: 48
Study 32038200 — intervention group
Group type: COMPARATOR
Intervention: Non-interactive VR (passive)
Number of subjects: 48
Study 32038200 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive eye tracked VR
Number of subjects: 48
Study 36055874 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 μg FMP013 / 0.5 mL ALFQ (Low dose group)
Number of subjects: 10
Study 36055874 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 μg FMP013 / 1.0 mL ALFQ (High dose group)
Number of subjects: 10
Study 36055874 — intervention group
Group type: COMPARATOR
Intervention: Historical responses reported for RTS,S/AS01
Number of subjects: 10
Study 34658151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Nd:YAG laser and intralesional bleomycin
Number of subjects: 40
Study 34658151 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Nd:YAG laser only
Number of subjects: 40
Study 36125053 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (2g daily for 6 weeks)
Number of subjects: 30
Study 36125053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 32522363 — intervention group
Group type: COMPARATOR
Intervention: 2-mm ferrule restoration (NPR2; control group)
Number of subjects: 32
Study 32522363 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5×0.5-mm ISRF (ISRF0.5)
Number of subjects: 32
Study 32522363 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mm CLP (CLP2)
Number of subjects: 32
Study 32522363 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mm OEP (OEP2)
Number of subjects: 32
Study 35169169 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (200 mL single transfusion)
Number of subjects: 103
Study 35169169 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo)
Number of subjects: 103
Study 33639024 — intervention group
Group type: EXPERIMENTAL
Intervention: Transformational leadership
Number of subjects: 344
Study 33639024 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional intelligence
Number of subjects: 344
Study 33639024 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall level of workplace social capital
Number of subjects: 344
Study 33639024 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall level of emotional intelligence
Number of subjects: 344
Study 33639024 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall level of organizational justice
Number of subjects: 344
Study 32134882 — intervention group
Group type: EXPERIMENTAL
Intervention: PowerPoint-based e-CBT delivered via email (12 weekly modules and homework assignments)
Number of subjects: 80
Study 32134882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80
Study 35973787 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT and anti-inflammatory diet (FMT-AID)
Number of subjects: 66
Study 35973787 — intervention group
Group type: COMPARATOR
Intervention: Anti-inflammatory diet alone
Number of subjects: 66
Study 35973787 — intervention group
Group type: COMPARATOR
Intervention: Optimised standard medical therapy (SMT)
Number of subjects: 66
Study 33497375 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% w/w metofluthrin emanators
Number of subjects: 200
Study 32735053 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week smartphone-based aftercare intervention with therapist feedback as add-on to treatment as usual (TAU)
Number of subjects: 186
Study 32735053 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 186
Study 35848060 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified video-feedback parenting intervention delivered in-home by trained mental health professionals over 4-6 months
Number of subjects: 30
Study 35848060 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study 33258495 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine showers and mupirocin nasal ointment twice a day for 5 days before surgery (S. aureus carrier group)
Number of subjects: 613
Study 33258495 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily chlorhexidine showers (noncarrier group)
Number of subjects: 613
Study 33105701 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) for 4 weeks, eating window limited to 10:00 - 19:00 h
Number of subjects: 19
Study 33105701 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) adherence
Number of subjects: 19